1 recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
Follow Sin Gon Kim: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study) Moderate-intensity statin monotherapy, Ezetimibe or ezetimibe-statin combination therapy - Dyslipidemia Associated With Type II Diabetes Mellitus | Not applicable | Recruiting | Sin Gon Kim | 2186 | 2026-03-09 | 2026-03-10 |
Diabetes Mellitus (1) · Dyslipidemias (1)
Ezetimibe (1)
South Korea (1)
Bong-Soo Cha, MD (1)